Clinical trial shows synthetic cannabis reduces agitation in Alzheimer’s disease

October 2, 2024 blogger Medicial Marijuana, Stop Smoking Marijuana, Stop Smoking Pot, weed, withdrawal

Researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic version of marijuana’s main ingredient, THC, reduces agitation in patients with Alzheimer’s by an average of 30%.

Buying Weed Based on the Highest THC Levels? – You Are Doing it Wrong, Look For This Instead! Chronic pain patients are more supportive of cannabis access than doctors